SCHEMBL6946746

SCHEMBL6946746

COc1ccc(C(=O)NCCc2ccccc2)c(CO)c1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.58
RAB9A P51151 7/20 0.58
KMT2A Q03164 4/20 0.58
MEN1 O00255 2/20 0.58
TACR3 P29371 1/20 0.57
MAPT P10636 2/20 0.57
CLK1 P49759 1/20 0.57
KDM4E B2RXH2 1/20 0.57
SLC6A5 Q9Y345 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
GAA P10253 1/20 0.55
TAAR1 Q96RJ0 1/20 0.55
AKR1C3 P42330 1/20 0.55
MTNR1A P48039 1/20 0.55
MTNR1B P49286 1/20 0.55
APP P05067 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2124884 0.81 NPC1 (0.59) NPC1RAB9AKMT2AMEN1KDM4E
SCHEMBL17554077 0.79 SMN1; SMN2 (0.70) NPC1RAB9AKMT2AMEN1TACR3
SCHEMBL7705937 0.77 ALDH1A1 (0.76) NPC1RAB9AKMT2AMEN1MAPT
SCHEMBL3102721 0.77 MTNR1A (0.57) NPC1RAB9AKMT2AMEN1KDM4E
SCHEMBL3236742 0.76 ALDH1A1 (0.62) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL28341413 0.76 RAB9A (0.76) NPC1RAB9AKMT2AMEN1MAPT
SCHEMBL30560618 0.76 NPC1 (0.57) NPC1RAB9AKMT2AMEN1TACR3
SCHEMBL17554153 0.76 NPC1 (0.57) NPC1RAB9AKMT2AMEN1TACR3
SCHEMBL17554032 0.76 RAB9A (0.64) NPC1RAB9AKMT2AMEN1TACR3
SCHEMBL6946739 0.75 MEN1 (0.58) KMT2AMEN1KDM4ESLC6A5GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0674623-B1 BICYCLIC FIBRINOGEN ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2003-04-09 EP disclosed
US-6403578-B1 ANTICOAGULANTS, CARDIOVASCULAR DISORDERS SMITHKLINE BEECHAM CORPORATION 2002-06-11 US disclosed
EP-0674623-A1 BICYCLIC FIBRINOGEN ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1995-10-04 EP disclosed
WO-1994014776-A2 BICYCLIC FIBRINOGEN ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1994-07-07 WO disclosed